Radiation myositis: the possible role of gemcitabine.
Ganem
G
G
Radiation Oncology Department, Centre Jean Bernard, Le Mans, France. coutard@cybercable.tm.fr
Solal-Celigny
P
P
Joffroy
A
A
Tassy
D
D
Delpon
A
A
Dupuis
O
O
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D002081:Buttocks / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009220:Myositis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D010146:Pain / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine